Literature DB >> 2924321

N-myc amplification and neuronal differentiation in human primitive neuroectodermal tumors of the central nervous system.

E Rouah1, D R Wilson, D L Armstrong, G J Darlington.   

Abstract

Despite the phenotypic similarities between primitive neuroectodermal tumors of the central nervous system, childhood neuroblastoma, and peripheral neuroepithelioma, a histogenetic relationship among these neoplasms has not been shown. High levels of N-myc expression occur selectively in developing brain and in some embryonic tumors of neural origin. N-myc amplification and high levels of N-myc expression in childhood neuroblastoma have been correlated with disease stage and prognosis. To determine whether the copy number of the N-myc gene in primitive neuroectodermal tumors of the central nervous system is altered, we examined 20 primitive neuroectodermal tumors by Southern and/or slot blot hybridization to a 1-kilobase N-myc genomic DNA sequence and a 492-base pair N-myc-specific subclone as well as to a 1.1-kilobase albumin complementary DNA sequence as a control for gene copy number. Amplification of the N-myc gene was detected in two cerebellar tumors both of which exhibited neuronal differentiation by light microscopy. These tumors had not been treated previously. Of the remaining 18 tumors, eight were undifferentiated, three showed early neuroblastic, and seven focal glial differentiation. These findings suggest a possible relationship between N-myc amplification and neuronal differentiation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2924321

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  N-myc oncogene amplification in a pediatric case of glioblastoma multiforme.

Authors:  A M Stenger; M L Garrè; A Cama; L Andreussi; M Brisigotti; G P Tonini; P Cornaglia-Ferraris
Journal:  Childs Nerv Syst       Date:  1991-11       Impact factor: 1.475

Review 2.  Genetic alterations of brain tumors.

Authors:  K von Ammon; U Roelcke
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

3.  Post-translational control of Myc function during differentiation.

Authors:  Maralice Conacci-Sorrell; Robert N Eisenman
Journal:  Cell Cycle       Date:  2011-02-15       Impact factor: 4.534

4.  Gene amplification in PNETs/medulloblastomas: mapping of a novel amplified gene within the MYCN amplicon.

Authors:  M C Frühwald; M S O'Dorisio; L J Rush; J L Reiter; D J Smiraglia; G Wenger; J F Costello; P S White; R Krahe; G M Brodeur; C Plass
Journal:  J Med Genet       Date:  2000-07       Impact factor: 6.318

Review 5.  Cellular and molecular pathology of medulloblastoma.

Authors:  J P Provias; L E Becker
Journal:  J Neurooncol       Date:  1996-07       Impact factor: 4.130

Review 6.  Genetic alterations in glioma and medulloblastoma.

Authors:  B K Rasheed; S H Bigner
Journal:  Cancer Metastasis Rev       Date:  1991-12       Impact factor: 9.264

Review 7.  Medulloblastoma: tumor biological and clinical perspectives.

Authors:  H S Friedman; W J Oakes; S H Bigner; C J Wikstrand; D D Bigner
Journal:  J Neurooncol       Date:  1991-08       Impact factor: 4.130

8.  Central neurocytomas with MIB-1 labeling index over 10% showing rapid tumor growth and dissemination.

Authors:  Yoshikazu Ogawa; Takayuki Sugawara; Hirobumi Seki; Tutomu Sakuma
Journal:  J Neurooncol       Date:  2006-03-22       Impact factor: 4.130

9.  Myc proteins in brain tumor development and maintenance.

Authors:  Fredrik J Swartling
Journal:  Ups J Med Sci       Date:  2012-02-21       Impact factor: 2.384

10.  Copy number gain of MYCN gene is a recurrent genetic aberration and favorable prognostic factor in Chinese pediatric neuroblastoma patients.

Authors:  Miao Wang; Chunju Zhou; Rongqin Cai; Yong Li; Liping Gong
Journal:  Diagn Pathol       Date:  2013-01-15       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.